Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Anne-Marie Cleton-Jansen
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Disorders
Anatomy
Genes & Molecular Sequences
Procedures
Concepts & Ideas
Chemicals & Drugs
Physiology
Phenomena
Sign-in to see full Profile
Network (preview)
33
Cornelisse, Cees
32
Hogendoorn, Pancras
23
Bovée, Judith
16
Taminiau, Antonie
14
Callen, David
11
Devilee, Peter
10
Crawford, Joanna
8
van de Vijver, Marc
8
Rozeman, Leida
8
Hameetman, Liesbeth
7
van Wezel, Tom
7
Whitmore, Scott
6
Oosting, Jan
6
van de Putte, P
6
van Eijk, Ronald
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Anne-Marie Cleton-Jansen (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2010: Ottaviano Laura; Schaefer Karl-Ludwig; Gajewski Melanie; Huckenbeck Wolfgang; Baldus Stefan; Rogel Uwe; Mackintosh Carlos; de Alava Enrique; Myklebost Ola; Kresse Stine H; Meza-Zepeda Leonardo A; Serra Massimo; Cleton-Jansen Anne-Marie; Hogendoorn Pancras C W; Buerger Horst; Aigner Thomas; Gabbert Helmut E; Poremba Christopher
Molecular characterization of commonly used cell lines for bone tumor research: A trans-European EuroBoNet effort.
Genes, chromosomes & cancer 2010;49(1):40-51.
-
2009: Mohseny Alexander B; Szuhai Karoly; Romeo Salvatore; Buddingh Emilie P; Briaire-de Bruijn Inge; de Jong Daniëlle; van Pel Melissa; Cleton-Jansen Anne-Marie; Hogendoorn Pancras C W
Osteosarcoma originates from mesenchymal stem cells in consequence of aneuploidization and genomic loss of Cdkn2.
The Journal of pathology 2009;219(3):294-305.
-
2009: Willems Stefan M; Mohseny Alex B; Balog Crina; Sewrajsing Raj; Briaire-de Bruijn Inge H; Knijnenburg Jeroen; Cleton-Jansen Anne-Marie; Sciot Raf; Fletcher Christopher D M; Deelder André M; Szuhai Karoly; Hensbergen Paul J; Hogendoorn Pancras C W
Cellular/intramuscular myxoma and grade I myxofibrosarcoma are characterized by distinct genetic alterations and specific composition of their extracellular matrix.
Journal of cellular and molecular medicine 2009;13(7):1291-301.
-
2009: Hallor Karolin H; Staaf Johan; Bovée Judith V M G; Hogendoorn Pancras C W; Cleton-Jansen Anne-Marie; Knuutila Sakari; Savola Suvi; Niini Tarja; Brosjö Otte; Bauer Henrik C F; Vult von Steyern Fredrik; Jonsson Kjell; Skorpil Mikael; Mandahl Nils; Mertens Fredrik
Genomic profiling of chondrosarcoma: chromosomal patterns in central and peripheral tumors.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(8):2685-94.
-
2009: Schrage Yvonne M; Hameetman Liesbeth; Szuhai Karoly; Cleton-Jansen Anne-Marie; Taminiau Antonie H M; Hogendoorn Pancras C W; Bovée Judith V M G
Aberrant heparan sulfate proteoglycan localization, despite normal exostosin, in central chondrosarcoma.
The American journal of pathology 2009;174(3):979-88.
-
2008: Cleton-Jansen Anne-Marie; van Eijk Ronald; Lombaerts Marcel; Schmidt Marjanka K; Van't Veer Laura J; Philippo Katja; Zimmerman Rhyenne M E; Peterse Johannes L; Smit Vincent T B H M; van Wezel Tom; Cornelisse Cees J
ATBF1 and NQO1 as candidate targets for allelic loss at chromosome arm 16q in breast cancer: absence of somatic ATBF1 mutations and no role for the C609T NQO1 polymorphism.
BMC cancer 2008;8():105.
-
2007: Gomes Célia M F; Welling Mick; Que Ivo; Henriquez Niek V; van der Pluijm Gabri; Romeo Salvatore; Abrunhosa Antero J; Botelho M Filomena; Hogendoorn Pancras C W; Pauwels Ernest K J; Cleton-Jansen Anne Marie
Functional imaging of multidrug resistance in an orthotopic model of osteosarcoma using 99mTc-sestamibi.
European journal of nuclear medicine and molecular imaging 2007;34(11):1793-803.
-
2007: Buijs Jeroen T; Henriquez Nico V; van Overveld Petra G M; van der Horst Geertje; Que Ivo; Schwaninger Ruth; Rentsch Cyrill; Ten Dijke Peter; Cleton-Jansen Anne-Marie; Driouch Keltouma; Lidereau Rosette; Bachelier Richard; Vukicevic Slobodan; Clézardin Philippe; Papapoulos Socrates E; Cecchini Marco G; Löwik Clemens W G M; van der Pluijm Gabri
Bone morphogenetic protein 7 in the development and treatment of bone metastases from breast cancer.
Cancer research 2007;67(18):8742-51.
-
2007: Romeo Salvatore; Oosting Jan; Rozeman Leida B; Hameetman Liesbeth; Taminiau Antonie H M; Cleton-Jansen Anne Marie; Bovée Judith V M G; Hogendoorn Pancras C W
The role of noncartilage-specific molecules in differentiation of cartilaginous tumors: lessons from chondroblastoma and chondromyxoid fibroma.
Cancer 2007;110(2):385-94.
-
2007: Hameetman Liesbeth; Szuhai Karoly; Yavas Ayse; Knijnenburg Jeroen; van Duin Mark; van Dekken Herman; Taminiau Antonie H M; Cleton-Jansen Anne-Marie; Bovée Judith V M G; Hogendoorn Pancras C W
The role of EXT1 in nonhereditary osteochondroma: identification of homozygous deletions.
Journal of the National Cancer Institute 2007;99(5):396-406.
-
2007: Hameetman L; David G; Yavas A; White S J; Taminiau A H M; Cleton-Jansen A-M; Hogendoorn P C W; Bovée J V M G
Decreased EXT expression and intracellular accumulation of heparan sulphate proteoglycan in osteochondromas and peripheral chondrosarcomas.
The Journal of pathology 2007;211(4):399-409.
-
2007: Grogan Shawn Patrick; Barbero Andrea; Diaz-Romero Jose; Cleton-Jansen Anne-Marie; Soeder Stephan; Whiteside Robert; Hogendoorn Pancras C W; Farhadi Jian; Aigner Thomas; Martin Ivan; Mainil-Varlet Pierre
Identification of markers to characterize and sort human articular chondrocytes with enhanced in vitro chondrogenic capacity.
Arthritis and rheumatism 2007;56(2):586-95.
-
2006: Rozeman L B; Cleton-Jansen A M; Hogendoorn P C W
Pathology of primary malignant bone and cartilage tumours.
International orthopaedics 2006;30(6):437-44.
-
2006: Gomes Celia Maria Freitas; van Paassen Heidi; Romeo Salvatore; Welling Mick M; Feitsma R I J; Abrunhosa Antero J; Botelho M Filomena; Hogendoorn Pancras C W; Pauwels Ernest; Cleton-Jansen Anne Marie
Multidrug resistance mediated by ABC transporters in osteosarcoma cell lines: mRNA analysis and functional radiotracer studies.
Nuclear medicine and biology 2006;33(7):831-40.
-
2006: Hameetman L; Rozeman L B; Lombaerts M; Oosting J; Taminiau A H M; Cleton-Jansen A-M; Bovée J V M G; Hogendoorn P C W
Peripheral chondrosarcoma progression is accompanied by decreased Indian Hedgehog signalling.
The Journal of pathology 2006;209(4):501-11.
-
2006: Rozeman Leida B; Szuhai Karoly; Schrage Yvonne M; Rosenberg Carla; Tanke Hans J; Taminiau Antonie H M; Cleton-Jansen Anne Marie; Bovée Judith V M G; Hogendoorn Pancras C W
Array-comparative genomic hybridization of central chondrosarcoma: identification of ribosomal protein S6 and cyclin-dependent kinase 4 as candidate target genes for genomic aberrations.
Cancer 2006;107(2):380-8.
-
2006: Oldenburg Rogier A; Kroeze-Jansema Karin; Meijers-Heijboer Hanne; van Asperen Cristi J; Hoogerbrugge Nicoline; van Leeuwen Inge; Vasen Hans F A; Cleton-Jansen Anne-Marie; Kraan Jaennelle; Houwing-Duistermaat Jeanine J; Morreau Hans; Cornelisse Cees J; Devilee Peter
Characterization of familial non-BRCA1/2 breast tumors by loss of heterozygosity and immunophenotyping.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(6):1693-700.
-
2006: Lombaerts M; van Wezel T; Philippo K; Dierssen J W F; Zimmerman R M E; Oosting J; van Eijk R; Eilers P H; van de Water B; Cornelisse C J; Cleton-Jansen A-M
E-cadherin transcriptional downregulation by promoter methylation but not mutation is related to epithelial-to-mesenchymal transition in breast cancer cell lines.
British journal of cancer 2006;94(5):661-71.
-
2005: Kumar Raman; Neilsen Paul M; Crawford Joanne; McKirdy Ross; Lee Jaclyn; Powell Jason A; Saif Zarqa; Martin Julie M; Lombaerts Marc; Cornelisse Cees J; Cleton-Jansen Anne-Marie; Callen David F
FBXO31 is the chromosome 16q24.3 senescence gene, a candidate breast tumor suppressor, and a component of an SCF complex.
Cancer research 2005;65(24):11304-13.
-
2005: Cleton-Jansen Anne-Marie; van Beerendonk Hetty M; Baelde Hans J; Bovée Judith V G M; Karperien Marcel; Hogendoorn Pancras C W
Estrogen signaling is active in cartilaginous tumors: implications for antiestrogen therapy as treatment option of metastasized or irresectable chondrosarcoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(22):8028-35.
-
2005: van Puijenbroek Marjo; Dierssen Jan Willem F; Stanssens Patrick; van Eijk Ronald; Cleton-Jansen Anne Marie; van Wezel Tom; Morreau Hans
Mass spectrometry-based loss of heterozygosity analysis of single-nucleotide polymorphism loci in paraffin embedded tumors using the MassEXTEND assay: single-nucleotide polymorphism loss of heterozygosity analysis of the protein tyrosine phosphatase receptor type J in familial colorectal cancer.
The Journal of molecular diagnostics : JMD 2005;7(5):623-30.
-
2005: Hauben Esther I; Jundt Gernot; Cleton-Jansen Anne-Marie; Yavas Ayse; Kroon Herman M; Van Marck Eric; Hogendoorn Pancras C W
Desmoplastic fibroma of bone: an immunohistochemical study including beta-catenin expression and mutational analysis for beta-catenin.
Human pathology 2005;36(9):1025-30.
-
2005: Rozeman Leida B; Hameetman Liesbeth; van Wezel Tom; Taminiau Antonie H M; Cleton-Jansen Anne Marie; Hogendoorn Pancras C W; Bovée Judith V M G
cDNA expression profiling of chondrosarcomas: Ollier disease resembles solitary tumours and alteration in genes coding for components of energy metabolism occurs with increasing grade.
The Journal of pathology 2005;207(1):61-71.
-
2005: Bovée Judith V M G; Cleton-Jansen Anne-Marie; Taminiau Antonie H M; Hogendoorn Pancras C W
Emerging pathways in the development of chondrosarcoma of bone and implications for targeted treatment.
The lancet oncology 2005;6(8):599-607.
-
2005: Natté Remco; van Eijk Ronald; Eilers Paul; Cleton-Jansen Anne-Marie; Oosting Jan; Kouwenhove Mathilde; Kros Johan M; van Duinen Sjoerd
Multiplex ligation-dependent probe amplification for the detection of 1p and 19q chromosomal loss in oligodendroglial tumors.
Brain pathology (Zurich, Switzerland) 2005;15(3):192-7.
-
2005: Romeo Salvatore; Bovée Judith V M G; Grogan Shawn P; Taminiau Antonie H M; Eilers Paul H C; Cleton-Jansen Anne Marie; Mainil-Varlet Pierre; Hogendoorn Pancras C W
Chondromyxoid fibroma resembles in vitro chondrogenesis, but differs in expression of signalling molecules.
The Journal of pathology 2005;206(2):135-42.
-
2005: Goeman Jelle J; Oosting Jan; Cleton-Jansen Anne-Marie; Anninga Jakob K; van Houwelingen Hans C
Testing association of a pathway with survival using gene expression data.
Bioinformatics (Oxford, England) 2005;21(9):1950-7.
-
2005: Hameetman Liesbeth; Kok Petra; Eilers Paul H C; Cleton-Jansen Anne-Marie; Hogendoorn Pancras C W; Bovée Judith V M G
The use of Bcl-2 and PTHLH immunohistochemistry in the diagnosis of peripheral chondrosarcoma in a clinicopathological setting.
Virchows Archiv : an international journal of pathology 2005;446(4):430-7.
-
2005: Rozeman Leida B; Hameetman Liesbeth; Cleton-Jansen Anne-Marie; Taminiau Anthonie H M; Hogendoorn Pancras C W; Bovée Judith V M G
Absence of IHH and retention of PTHrP signalling in enchondromas and central chondrosarcomas.
The Journal of pathology 2005;205(4):476-82.
-
2005: van Wezel Tom; Lombaerts Marcel; van Roon Eddy H; Philippo Katja; Baelde Hans J; Szuhai Karoly; Cornelisse Cees J; Cleton-Jansen Anne-Marie
Expression analysis of candidate breast tumour suppressor genes on chromosome 16q.
Breast cancer research : BCR 2005;7(6):R998-1004.
-
2004: Rozeman Leida B; Sangiorgi Luca; Briaire-de Bruijn Inge H; Mainil-Varlet Pierre; Bertoni F; Cleton-Jansen Anne Marie; Hogendoorn Pancras C W; Bovée Judith V M G
Enchondromatosis (Ollier disease, Maffucci syndrome) is not caused by the PTHR1 mutation p.R150C.
Human mutation 2004;24(6):466-73.
-
2004: Cleton-Jansen Anne-Marie; Buerger Horst; Haar Natalja ter; Philippo Katja; van de Vijver Marc J; Boecker Werner; Smit Vincent T H B M; Cornelisse Cees J
Different mechanisms of chromosome 16 loss of heterozygosity in well- versus poorly differentiated ductal breast cancer.
Genes, chromosomes & cancer 2004;41(2):109-16.
-
2004: Lombaerts Marcel; Middeldorp Janneke W; van der Weide Esther; Philippo Katja; van Wezel Tom; Smit Vincent T H B M; Cornelisse Cees J; Cleton-Jansen Anne-Marie
Infiltrating leukocytes confound the detection of E-cadherin promoter methylation in tumors.
Biochemical and biophysical research communications 2004;319(2):697-704.
-
2004: Anninga J K; van de Vijver M J; Cleton-Jansen A M; Kristel P M P; Taminiau A H M; Nooij M; Egeler R M; Hogendoorn P C W
Overexpression of the HER-2 oncogene does not play a role in high-grade osteosarcomas.
European journal of cancer (Oxford, England : 1990) 2004;40(7):963-70.
-
2004: van Eijk Ronald; Oosting Jan; Sieben Nathalie; van Wezel Tom; Cleton-Jansen Anne-Marie
Visualization of regional gene expression biases by microarray data sorting.
BioTechniques 2004;36(4):592-4, 596.
-
2004: van Beerendonk Hetty M; Rozeman Leida B; Taminiau Antonie H M; Sciot Raf; Bovée Judith V M G; Cleton-Jansen Anne-Marie; Hogendoorn Pancras C W
Molecular analysis of the INK4A/INK4A-ARF gene locus in conventional (central) chondrosarcomas and enchondromas: indication of an important gene for tumour progression.
The Journal of pathology 2004;202(3):359-66.
-
2004: Cleton-Jansen Anne-Marie; Timmerman Michel C; van de Vijver Marc J; van Asperen Christi J; Kroon Herman M; Eilers Paul H C; Hogendoorn Pancras C W
A distinct phenotype characterizes tumors from a putative genetic trait involving chondrosarcoma and breast cancer occurring in the same patient.
Laboratory investigation; a journal of technical methods and pathology 2004;84(2):191-202.
-
2003: Sieben Nathalie L G; Kolkman-Uljee Sandra M; Flanagan Adrienne M; le Cessie Saskia; Cleton-Jansen Anne-Marie; Cornelisse Cees J; Fleuren Gert Jan
Molecular genetic evidence for monoclonal origin of bilateral ovarian serous borderline tumors.
The American journal of pathology 2003;162(4):1095-101.
-
2002: Becker Karl-Friedrich; Kremmer Elisabeth; Eulitz Manfred; Schulz Stephan; Mages Jörg; Handschuh Gabriele; Wheelock Margaret J; Cleton-Jansen Anne-Marie; Höfler Heinz; Becker Ingrid
Functional allelic loss detected at the protein level in archival human tumours using allele-specific E-cadherin monoclonal antibodies.
The Journal of pathology 2002;197(5):567-74.
-
2002: Kochetkova Marina; McKenzie Olivia L D; Bais Anthony J; Martin Julie M; Secker Genevieve A; Seshadri Ram; Powell Jason A; Hinze Susan J; Gardner Alison E; Spendlove Hayley E; O'Callaghan Nathan J; Cleton-Jansen Anne-Marie; Cornelisse Cees; Whitmore Scott A; Crawford Joanna; Kremmidiotis Gabriel; Sutherland Grant R; Callen David F
CBFA2T3 (MTG16) is a putative breast tumor suppressor gene from the breast cancer loss of heterozygosity region at 16q24.3.
Cancer research 2002;62(16):4599-604.
-
2002: Callen David F; Crawford Joanne; Derwas Cathy; Cleton-Jansen Anne-Marie; Cornelisse Cees J; Baker Elizabeth
Defining regions of loss of heterozygosity of 16q in breast cancer cell lines.
Cancer genetics and cytogenetics 2002;133(1):76-82.
-
2002: Filippova Galina N; Qi Chen-Feng; Ulmer Jonathan E; Moore James M; Ward Michael D; Hu Ying J; Loukinov Dmitri I; Pugacheva Elena M; Klenova Elena M; Grundy Paul E; Feinberg Andrew P; Cleton-Jansen Anne-Marie; Moerland Elna W; Cornelisse Cees J; Suzuki Hiroyoshi; Komiya Akira; Lindblom Annika; Dorion-Bonnet Françoise; Neiman Paul E; Morse Herbert C; Collins Steven J; Lobanenkov Victor V
Tumor-associated zinc finger mutations in the CTCF transcription factor selectively alter tts DNA-binding specificity.
Cancer research 2002;62(1):48-52.
-
2002: Cleton-Jansen Anne-Marie
E-cadherin and loss of heterozygosity at chromosome 16 in breast carcinogenesis: different genetic pathways in ductal and lobular breast cancer?
Breast cancer research : BCR 2002;4(1):5-8.
-
2001: Baelde H J; Cleton-Jansen A M; van Beerendonk H; Namba M; Bovée J V; Hogendoorn P C
High quality RNA isolation from tumours with low cellularity and high extracellular matrix component for cDNA microarrays: application to chondrosarcoma.
Journal of clinical pathology 2001;54(10):778-82.
-
2001: Bovée J V; van Den Broek L J; Cleton-Jansen A M; Hogendoorn P C
Chondrosarcoma is not characterized by detectable telomerase activity.
The Journal of pathology 2001;193(3):354-60.
-
2001: Cleton-Jansen A M; Callen D F; Seshadri R; Goldup S; Mccallum B; Crawford J; Powell J A; Settasatian C; van Beerendonk H; Moerland E W; Smit V T; Harris W H; Millis R; Morgan N V; Barnes D; Mathew C G; Cornelisse C J
Loss of heterozygosity mapping at chromosome arm 16q in 712 breast tumors reveals factors that influence delineation of candidate regions.
Cancer research 2001;61(3):1171-7.
-
2001: Langezaal S M; Graadt van Roggen J F; Cleton-Jansen A M; Baelde J J; Hogendoorn P C
Malignant melanoma is genetically distinct from clear cell sarcoma of tendons and aponeurosis (malignant melanoma of soft parts).
British journal of cancer 2001;84(4):535-8.
-
2001: Odink A E; van Asperen C J; Vandenbroucke J P; Cleton-Jansen A M; Hogendoorn P C
An association between cartilaginous tumours and breast cancer in the national pathology registration in The Netherlands points towards a possible genetic trait.
The Journal of pathology 2001;193(2):190-2.
-
2000: Bovée J V; van den Broek L J; Cleton-Jansen A M; Hogendoorn P C
Up-regulation of PTHrP and Bcl-2 expression characterizes the progression of osteochondroma towards peripheral chondrosarcoma and is a late event in central chondrosarcoma.
Laboratory investigation; a journal of technical methods and pathology 2000;80(12):1925-34.
-
2000: Sieben N L; ter Haar N T; Cornelisse C J; Fleuren G J; Cleton-Jansen A M
PCR artifacts in LOH and MSI analysis of microdissected tumor cells.
Human pathology 2000;31(11):1414-9.
-
2000: Bovée J V; van Royen M; Bardoel A F; Rosenberg C; Cornelisse C J; Cleton-Jansen A M; Hogendoorn P C
Near-haploidy and subsequent polyploidization characterize the progression of peripheral chondrosarcoma.
The American journal of pathology 2000;157(5):1587-95.
-
2000: Bovée J V; van Roggen J F; Cleton-Jansen A M; Taminiau A H; van der Woude H J; Hogendoorn P C
Malignant progression in multiple enchondromatosis (Ollier's disease): an autopsy-based molecular genetic study.
Human pathology 2000;31(10):1299-303.
-
2000: Bonsing B A; Corver W E; Fleuren G J; Cleton-Jansen A M; Devilee P; Cornelisse C J
Allelotype analysis of flow-sorted breast cancer cells demonstrates genetically related diploid and aneuploid subpopulations in primary tumors and lymph node metastases.
Genes, chromosomes & cancer 2000;28(2):173-83.
-
2000: van der Looij M; Cleton-Jansen A M; van Eijk R; Morreau H; van Vliet M; Kuipers-Dijkshoorn N; Oláh E; Cornelisse C J; Devilee P
A sporadic breast tumor with a somatically acquired complex genomic rearrangement in BRCA1.
Genes, chromosomes & cancer 2000;27(3):295-302.
-
1999: Bovée J V; Cleton-Jansen A M; Rosenberg C; Taminiau A H; Cornelisse C J; Hogendoorn P C
Molecular genetic characterization of both components of a dedifferentiated chondrosarcoma, with implications for its histogenesis.
The Journal of pathology 1999;189(4):454-62.
-
1999: Vos C B; ter Haar N T; Rosenberg C; Peterse J L; Cleton-Jansen A M; Cornelisse C J; van de Vijver M J
Genetic alterations on chromosome 16 and 17 are important features of ductal carcinoma in situ of the breast and are associated with histologic type.
British journal of cancer 1999;81(8):1410-8.
-
1999: Bovée J V; Cleton-Jansen A M; Kuipers-Dijkshoorn N J; van den Broek L J; Taminiau A H; Cornelisse C J; Hogendoorn P C
Loss of heterozygosity and DNA ploidy point to a diverging genetic mechanism in the origin of peripheral and central chondrosarcoma.
Genes, chromosomes & cancer 1999;26(3):237-46.
-
1999: Savino M; d'Apolito M; Centra M; van Beerendonk H M; Cleton-Jansen A M; Whitmore S A; Crawford J; Callen D F; Zelante L; Savoia A
Characterization of copine VII, a new member of the copine family, and its exclusion as a candidate in sporadic breast cancers with loss of heterozygosity at 16q24.3.
Genomics 1999;61(2):219-26.
-
1999: Bovée J V; Cleton-Jansen A M; Wuyts W; Caethoven G; Taminiau A H; Bakker E; Van Hul W; Cornelisse C J; Hogendoorn P C
EXT-mutation analysis and loss of heterozygosity in sporadic and hereditary osteochondromas and secondary chondrosarcomas.
American journal of human genetics 1999;65(3):689-98.
-
1999: Settasatian C; Whitmore S A; Crawford J; Bilton R L; Cleton-Jansen A M; Sutherland G R; Callen D F
Genomic structure and expression analysis of the spastic paraplegia gene, SPG7.
Human genetics 1999;105(1-2):139-44.
-
1999: Cleton-Jansen A M; Moerland E W; Pronk J C; van Berkel C G; Apostolou S; Crawford J; Savoia A; Auerbach A D; Mathew C G; Callen D F; Cornelisse C J
Mutation analysis of the Fanconi anaemia A gene in breast tumours with loss of heterozygosity at 16q24.3.
British journal of cancer 1999;79(7-8):1049-52.
-
1999: Crawford J; Ianzano L; Savino M; Whitmore S; Cleton-Jansen A M; Settasatian C; d'apolito M; Seshadri R; Pronk J C; Auerbach A D; Verlander P C; Mathew C G; Tipping A J; Doggett N A; Zelante L; Callen D F; Savoia A
The PISSLRE gene: structure, exon skipping, and exclusion as tumor suppressor in breast cancer.
Genomics 1999;56(1):90-7.
-
1998: Whitmore S A; Settasatian C; Crawford J; Lower K M; McCallum B; Seshadri R; Cornelisse C J; Moerland E W; Cleton-Jansen A M; Tipping A J; Mathew C G; Savnio M; Savoia A; Verlander P; Auerbach A D; Van Berkel C; Pronk J C; Doggett N A; Callen D F
Characterization and screening for mutations of the growth arrest-specific 11 (GAS11) and C16orf3 genes at 16q24.3 in breast cancer.
Genomics 1998;52(3):325-31.
-
1998: Whitmore S A; Crawford J; Apostolou S; Eyre H; Baker E; Lower K M; Settasatian C; Goldup S; Seshadri R; Gibson R A; Mathew C G; Cleton-Jansen A M; Savoia A; Pronk J C; Auerbach A D; Doggett N A; Sutherland G R; Callen D F
Construction of a high-resolution physical and transcription map of chromosome 16q24.3: a region of frequent loss of heterozygosity in sporadic breast cancer.
Genomics 1998;50(1):1-8.
-
1997: De Leeuw W J; Berx G; Vos C B; Peterse J L; Van de Vijver M J; Litvinov S; Van Roy F; Cornelisse C J; Cleton-Jansen A M
Simultaneous loss of E-cadherin and catenins in invasive lobular breast cancer and lobular carcinoma in situ.
The Journal of pathology 1997;183(4):404-11.
-
1997: Ianzano L; D'Apolito M; Centra M; Savino M; Levran O; Auerbach A D; Cleton-Jansen A M; Doggett N A; Pronk J C; Tipping A J; Gibson R A; Mathew C G; Whitmore S A; Apostolou S; Callen D F; Zelante L; Savoia A
The genomic organization of the Fanconi anemia group A (FAA) gene.
Genomics 1997;41(3):309-14.
-
1997: Devilee P; Hermans J; Eyfjörd J; Bøorresen A L; Lidereau R; Sobol H; Borg A; Cleton-Jansen A M; Oláh E; Cohen B B; Scherneck S; Hamann U; Peterlin B; Caligo M; Bignon Y J; Maugard C
Loss of heterozygosity at 7q31 in breast cancer: results from an International Collaborative Study Group. The Breast Cancer Somatic Genetics Consortium.
Genes, chromosomes & cancer 1997;18(3):193-9.
-
1997: Moerland E; Breuning M H; Cornelisse C J; Cleton-Jansen A M
Exclusion of BBC1 and CMAR as candidate breast tumour-suppressor genes.
British journal of cancer 1997;76(12):1550-3.
-
1997: Vos C B; Cleton-Jansen A M; Berx G; de Leeuw W J; ter Haar N T; van Roy F; Cornelisse C J; Peterse J L; van de Vijver M J
E-cadherin inactivation in lobular carcinoma in situ of the breast: an early event in tumorigenesis.
British journal of cancer 1997;76(9):1131-3.
-
1996: Berx G; Cleton-Jansen A M; Strumane K; de Leeuw W J; Nollet F; van Roy F; Cornelisse C
E-cadherin is inactivated in a majority of invasive human lobular breast cancers by truncation mutations throughout its extracellular domain.
Oncogene 1996;13(9):1919-25.
-
1996: Peelen T; Cornelis R S; van Vliet M; Petrij-Bosch A; Cleton-Jansen A M; Meijers-Heijboer H; Klijn J G; Vasen H F; Cornelisse C J; Devilee P
The majority of 22 Dutch high-risk breast cancer families are due to either BRCA1 or BRCA2.
European journal of human genetics : EJHG 1996;4(4):225-30.
-
1995: Berx G; Cleton-Jansen A M; Nollet F; de Leeuw W J; van de Vijver M; Cornelisse C; van Roy F
E-cadherin is a tumour/invasion suppressor gene mutated in human lobular breast cancers.
The EMBO journal 1995;14(24):6107-15.
-
1995: Cleton-Jansen A M; Collins N; Lakhani S R; Weissenbach J; Devilee P; Cornelisse C J; Stratton M R
Loss of heterozygosity in sporadic breast tumours at the BRCA2 locus on chromosome 13q12-q13.
British journal of cancer 1995;72(5):1241-4.
-
1995: Cleton-Jansen A M; Moerland H W; Callen D F; Doggett N A; Devilee P; Cornelisse C J
Mapping of the breast basic conserved gene (D16S444E) to human chromosome band 16q24.3.
Cytogenetics and cell genetics 1995;68(1-2):49-51.
-
1994: Cornelis R S; van Vliet M; Vos C B; Cleton-Jansen A M; van de Vijver M J; Peterse J L; Khan P M; Børresen A L; Cornelisse C J; Devilee P
Evidence for a gene on 17p13.3, distal to TP53, as a target for allele loss in breast tumors without p53 mutations.
Cancer research 1994;54(15):4200-6.
-
1994: Wooster R; Cleton-Jansen A M; Collins N; Mangion J; Cornelis R S; Cooper C S; Gusterson B A; Ponder B A; von Deimling A; Wiestler O D
Instability of short tandem repeats (microsatellites) in human cancers.
Nature genetics 1994;6(2):152-6.
-
1994: Cleton-Jansen A M; Moerland E W; Kuipers-Dijkshoorn N J; Callen D F; Sutherland G R; Hansen B; Devilee P; Cornelisse C J
At least two different regions are involved in allelic imbalance on chromosome arm 16q in breast cancer.
Genes, chromosomes & cancer 1994;9(2):101-7.
-
1994: Cleton-Jansen A M; Moerland H W; Vossen R H; Callen D F; Breuning M H; Devilee P
Dinucleotide repeat polymorphism at D16S533.
Human molecular genetics 1994;3(1):216.
-
1993: Bonsing B A; Devilee P; Cleton-Jansen A M; Kuipers-Dijkshoorn N; Fleuren G J; Cornelisse C J
Evidence for limited molecular genetic heterogeneity as defined by allelotyping and clonal analysis in nine metastatic breast carcinomas.
Cancer research 1993;53(16):3804-11.
-
1991: Cleton-Jansen A M; Dekker S; van de Putte P; Goosen N
A single amino acid substitution changes the substrate specificity of quinoprotein glucose dehydrogenase in Gluconobacter oxydans.
Molecular & general genetics : MGG 1991;229(2):206-12.
-
1990: Cleton-Jansen A M; Goosen N; Fayet O; van de Putte P
Cloning, mapping, and sequencing of the gene encoding Escherichia coli quinoprotein glucose dehydrogenase.
Journal of bacteriology 1990;172(11):6308-15.
-
1989: Cleton-Jansen A M; Goosen N; Vink K; van de Putte P
Cloning, characterization and DNA sequencing of the gene encoding the Mr 50,000 quinoprotein glucose dehydrogenase from Acinetobacter calcoaceticus.
Molecular & general genetics : MGG 1989;217(2-3):430-6.
-
1989: Cleton-Jansen A M; Goosen N; Vink K; van de Putte P
Cloning of the genes encoding the two different glucose dehydrogenases from Acinetobacter calcoaceticus.
Antonie van Leeuwenhoek 1989;56(1):73-9.
-
1988: Cleton-Jansen A M; Goosen N; Odle G; van de Putte P
Nucleotide sequence of the gene coding for quinoprotein glucose dehydrogenase from Acinetobacter calcoaceticus.
Nucleic acids research 1988;16(13):6228.
-
1988: Cleton-Jansen A M; Goosen N; Wenzel T J; van de Putte P
Cloning of the gene encoding quinoprotein glucose dehydrogenase from Acinetobacter calcoaceticus: evidence for the presence of a second enzyme.
Journal of bacteriology 1988;170(5):2121-5.
Sign-in to see more
